SLC20A1P2

Across TCGA pan-cancer cohorts, SLC20A1P2 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SLC20A1P2’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where SLC20A1P2 RNA is repressed in tumor relative to normal tissue. In most cancer types SLC20A1P2 is over-expressed in tumor, although a few such as LUSC and BRCA show the opposite, repressed pattern.

LUSC, BRCA, and UCEC are the cancer types where SLC20A1P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC20A1P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	−0.062	<.001	4	view →
BRCA	All	II,III,IV	−0.021	.011	4	view →
UCEC	All	All	−0.044	.031	2	view →
THCA	All	All	−0.033	.003	2	view →
STAD	Male	All	−0.031	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SLC20A1P2–LUSC

Open the LUSC breakdown →